Source: Manufacturing Chemist

Indivumed GmbH: Veraxa and Indivumed cooperate on precision oncology antibodies

Veraxa uses microfluidic technology for the screening of antibodies with modulatory function on complex signal proteins like GPCRs or ion channels

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Hartmut Juhl's photo - Founder & CEO of Indivumed GmbH

Founder & CEO

Hartmut Juhl

CEO Approval Rating

82/100

Read more